Pfizer will report earnings on Tuesday before the market open. The FMHR traders debate the bull and the bear case for the stock. Barbara Ryan, FTI Strategic Communications, shares her recommendations for investing in pharma stocks now.
CNBC's Brian Shactman reports 8 Dow components hit new highs today including Pfizer; and Don Luskin, Trend Macro and Jim LaCamp, UBS, discuss how Wall Street is reacting to the debt debate, and where stocks go from here.
CVS says it won't carry Johnson & Johnson's Tylenol products in all of its stores, and Pfizer is the subject of breakup speculation according to some reports. Enis Taner, RiskReversal.com and Steve Cortes, Veracruz, discuss which drug stock is a better...
The entrance of Pfizer World headquaters in New York City, August 31, 2003. ECONM REUTERS/Jeff Christensen JC